Theseus Pharmaceuticals, Inc.
THRX · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$50,608 | -$27,308 | -$11,997 | -$7,183 |
| Dep. & Amort. | $50 | $2 | $2 | $2 |
| Deferred Tax | $0 | -$4,361 | $0 | $0 |
| Stock-Based Comp. | $11,412 | $4,361 | $1,052 | $317 |
| Change in WC | $6,551 | -$4,248 | $933 | -$179 |
| Other Non-Cash | -$350 | $4,361 | $5,158 | $2,236 |
| Operating Cash Flow | -$32,945 | -$27,193 | -$4,852 | -$4,807 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$455 | $12 | $0 | $0 |
| Net Acquisitions | $117 | $0 | $0 | $0 |
| Inv. Purchases | -$191,439 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $74,600 | $0 | $0 | $0 |
| Other Inv. Act. | -$117 | $0 | $0 | $0 |
| Investing Cash Flow | -$117,294 | $12 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $166,242 | $11,992 | $2,993 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $182 | $263,777 | $11,992 | $2,993 |
| Financing Cash Flow | $0 | $263,777 | $11,992 | $2,993 |
| Forex Effect | $0 | -$12 | $0 | $0 |
| Net Chg. in Cash | -$150,057 | $236,584 | $7,140 | -$1,814 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $245,041 | $8,457 | $1,317 | $3,131 |
| End Cash | $94,984 | $245,041 | $8,457 | $1,317 |
| Free Cash Flow | -$33,400 | -$27,181 | -$4,852 | -$4,807 |